J. Martin Carroll

Insider Reports History

Entity
Individual
Location
C/O Catalent, Inc., 14 Schoolhouse Road, Somerset, NJ
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by J. Martin Carroll:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Catalent, Inc. Director Common Stock 28.1K $1.04M $37.18 Oct 27, 2023 Direct
TherapeuticsMD, Inc. Director Common Stock 107K $239K $2.24 Aug 10, 2021 Direct
Esperion Therapeutics, Inc. Director Common Stock 64.7K $161K $2.48 May 23, 2024 Direct
Esperion Therapeutics, Inc. Director Stock Option (right to buy) 32.5K May 23, 2024 Direct
TherapeuticsMD, Inc. Director Restricted Stock Units 0 $3.64 Aug 10, 2021 Direct

Insider Reports Filed by J. Martin Carroll

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. May 23, 2024 2 $0 4 May 24, 2024 Director
CTLT Catalent, Inc. Oct 27, 2023 1 $0 4 Oct 31, 2023 Director
CTLT Catalent, Inc. Jul 1, 2023 1 $0 4 Jul 7, 2023 Director
ESPR Esperion Therapeutics, Inc. Jun 15, 2023 2 $0 4 Jun 16, 2023 Director
ESPR Esperion Therapeutics, Inc. May 10, 2023 2 $48.8K 4 May 11, 2023 Director
CTLT Catalent, Inc. Oct 27, 2022 1 $0 4 Oct 31, 2022 Director
MNKPF Mallinckrodt plc Jun 16, 2022 0 $0 4 Jun 21, 2022 Director
ESPR Esperion Therapeutics, Inc. Jun 2, 2022 1 $28.2K 4 Jun 3, 2022 Director
ESPR Esperion Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 1, 2022 Director
ESPR Esperion Therapeutics, Inc. Jun 1, 2022 0 $0 3 Jun 1, 2022 Director
CTLT Catalent, Inc. Nov 29, 2021 4 $0 4 Dec 1, 2021 Director
CTLT Catalent, Inc. Oct 28, 2021 1 $0 4 Nov 1, 2021 Director
TXMD TherapeuticsMD, Inc. Aug 10, 2021 2 $0 4 Aug 12, 2021 Director
TXMD TherapeuticsMD, Inc. Jul 1, 2021 1 $0 4 Jul 2, 2021 Director